Search by Drug Name or NDC
NDC 65862-0935-74 Aurovela 1.5/30 30; 1.5 ug/1; mg/1 Details
Aurovela 1.5/30 30; 1.5 ug/1; mg/1
Aurovela 1.5/30 is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is ETHINYL ESTRADIOL; NORETHINDRONE ACETATE.
Product Information
| NDC | 65862-0935 |
|---|---|
| Product ID | 65862-935_07926174-446c-43dc-9db1-db8b78432645 |
| Associated GPIs | 25990002600320 |
| GCN Sequence Number | 003304 |
| GCN Sequence Number Description | norethindrone ac-eth estradiol TABLET 1.5-0.03MG ORAL |
| HIC3 | G8A |
| HIC3 Description | CONTRACEPTIVES,ORAL |
| GCN | 11480 |
| HICL Sequence Number | 001455 |
| HICL Sequence Number Description | NORETHINDRONE ACETATE-ETHINYL ESTRADIOL |
| Brand/Generic | Generic |
| Proprietary Name | Aurovela 1.5/30 |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Norethindrone Acetate and Ethinyl Estradiol |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 30; 1.5 |
| Active Ingredient Units | ug/1; mg/1 |
| Substance Name | ETHINYL ESTRADIOL; NORETHINDRONE ACETATE |
| Labeler Name | Aurobindo Pharma Limited |
| Pharmaceutical Class | Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA207581 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 65862-0935-74 (65862093574)
| NDC Package Code | 65862-935-74 |
|---|---|
| Billing NDC | 65862093574 |
| Package | 3 POUCH in 1 CARTON (65862-935-74) / 1 BLISTER PACK in 1 POUCH / 21 TABLET in 1 BLISTER PACK |
| Marketing Start Date | 2017-06-26 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.52638 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | AUROVELA 21 1.5-30 TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis